NDMA attapulgite study
This article was originally published in The Tan Sheet
Executive Summary
Protocol submitted to FDA on April 8 to support the efficacy of attapulgite for treatment of acute nonspecific diarrhea. NDMA said that the protocol provides several options for proceeding with the study and that it is awaiting comment from FDA on which options would be preferable. FDA and NDMA met to discuss the attapulgite study at a recent feedback meeting ("The Tan Sheet" Jan. 31, p. 8)